{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T16:29:29Z","timestamp":1726849769430},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"suppl_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,10,1]]},"DOI":"10.1093\/ajhp\/57.suppl_1.s26","type":"journal-article","created":{"date-parts":[[2019,1,3]],"date-time":"2019-01-03T01:59:09Z","timestamp":1546480749000},"page":"S26-S30","source":"Crossref","is-referenced-by-count":5,"title":["Factors to consider in selecting an angiotensin-converting-enzyme inhibitor"],"prefix":"10.1093","volume":"57","author":[{"given":"William J.","family":"Waugh","sequence":"first","affiliation":[{"name":"Wellpoint Pharmacy Management, 4553 LaTienda Drive, T1-2-C5G, Thousand Oaks, CA 91362"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/57\/suppl_1\/S26\/28426538\/ajhp0s26.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T09:59:23Z","timestamp":1555322363000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/57\/suppl_1\/S26\/5156915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,10,1]]},"references-count":0,"journal-issue":{"issue":"suppl_1","published-print":{"date-parts":[[2000,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/57.suppl_1.s26","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2000,10,1]]},"published":{"date-parts":[[2000,10,1]]}}}